With an estimated 354,864 new cases reported globally in 2020 alone, oral cancer accounts for one-third of head and neck cancers in the United States and half of cases worldwide. Despite this, there is no clinical, biochemical, or molecular way to predict the cancer progression of oral premalignancy mucosal lesions (OPML). Additionally, there are no […]
